Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Franjo Naji"'
Autor:
David Šuran, Helena Blažun Vošner, Jernej Završnik, Peter Kokol, Andreja Sinkovič, Vojko Kanič, Marko Kokol, Franjo Naji, Tadej Završnik
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Lipoprotein(a) [Lp(a)] is a complex polymorphic lipoprotein comprised of a low-density lipoprotein particle with one molecule of apolipoprotein B100 and an additional apolipoprotein(a) connected through a disulfide bond. The serum concentration is mo
Externí odkaz:
https://doaj.org/article/66ca11ca39f643da8b22c3687320b4b9
Autor:
David Šuran, Vojko Kanič, Franjo Naji, Igor Krajnc, Miro Čokolič, Eva Zemljič, Andreja Sinkovič
Publikováno v:
Biomolecules & Biomedicine, Vol 19, Iss 4 (2019)
In patients with type 1 diabetes mellitus (T1DM) imaging studies have demonstrated an increased prevalence of left ventricular diastolic dysfunction and increased left ventricular mass (LVM) unrelated to arterial hypertension and ischemic heart disea
Externí odkaz:
https://doaj.org/article/8dcdd5b114de4885926f7aaa6c0dfe50
Publikováno v:
Acta Medico-Biotechnica. 11:32-38
Purpuse: Idiopathic right ventricular outflow tract ventricular tachycardia (RVOT-VT) is the most frequent type of ventricular arrhythmia in patients without structural heart disease and is frequently treated using radiofrequency ablation (RFA). Fast
Publikováno v:
Acta Medico-Biotechnica. 14:34-40
Purpose: There are no data demonstrating that a decrease in heart rate reduces periprocedural myocardial injury (PMI) in patients undergoing elective percutaneous coronary intervention (PCI). Ivabradine is an established anti-ischemic drug that reduc
Autor:
David Šuran, Tadej Završnik, Peter Kokol, Marko Kokol, Andreja Sinkovič, Franjo Naji, Jernej Završnik, Helena Blažun Vošner, Vojko Kanič
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 9; Pages: 3220
Introduction: Lipoprotein(a) (Lp(a)) is a well-recognised risk factor for ischemic heart disease (IHD) and calcific aortic valve stenosis (AVS). Methods: A retrospective observational study of Lp(a) levels (mg/dL) in patients hospitalised for cardiov
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Introduction Functional changes in peripheral arterial disease (PAD) could play a role in higher cardiovascular risk in these patients. Methods 123 patients who underwent elective coronary angiography were included. Ankle-brachial index (ABI) was mea
Publikováno v:
Clinical Nephrology. 96:43-48
Background Cystatin C (cysC) is freely filtered in the glomeruli, and its serum concentration is independent of muscle mass, diet, gender, or age. In patients with chronic kidney disease (CKD), cysC is associated with advanced atherosclerosis and inc
Publikováno v:
Slovenian Journal of Public Health
Slovenian Journal of Public Health, Vol 59, Iss 2, Pp 108-116 (2020)
Slovenian Journal of Public Health, Vol 59, Iss 2, Pp 108-116 (2020)
Heart rhythm disorders (HRD) are often present in patients visiting their family physician (FP). Dealing with their problems is not always simple, efficient and cost effective. The aim of this paper is to review the existing literature about the use
Publikováno v:
Genes, vol. 13, no. 3, 526, 2022.
Genes; Volume 13; Issue 3; Pages: 526
Genes; Volume 13; Issue 3; Pages: 526
Background: We examined the role of rs1333049 polymorphism of the CDKN2B Antisense RNA 1 (CDKN2B-AS1) on the prevalence of myocardial infarction (MI) in Slovenian subjects with type 2 diabetes mellitus (T2DM). Methods: A total of 1071 subjects with T
Publikováno v:
Zdravniški Vestnik, Vol 88, Iss 7-8, Pp 327-337 (2019)
Background Data on the relationship between radial access (RA) and outcome in patients with myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI) are inconclusive. The aim of our study was to assess whether RA is associated w